| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |